Association of urokinase-type plasminogen activator with asthma and atopy

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 11, 2007, Pages 1109-1116

  Bégin, Philippe ^a   Tremblay, Karine ^a,b   Daley, Denise ^c   Lemire, Mathieu ^d   Claveau, Sébastien ^a,e   Salesse, Charleen ^a,e   Kacel, Sabine ^a,e   Montpetit, Alexandre ^d   Becker, Allan ^f   Chan Yeung, Moira ^f   Kozyrskyj, Anita L ^f,g   Hudson, Thomas J ^h   Laprise, Catherine ^a,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

Airway hyperresponsiveness; Association study; Asthma; Atopy; Haplotypes; Urokinase type plasminogen activator gene

Indexed keywords

UROKINASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASTHMA; ATOPY; CANADA; CHILD; CONTROLLED STUDY; DOMINANT GENE; FAMILY ASSESSMENT; FEMALE; FRANCE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAMPLING; SERIAL ANALYSIS OF GENE EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASTHMA; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROGNOSIS; QUEBEC; URINARY PLASMINOGEN ACTIVATOR;

EID: 34249800938     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200607-1012OC     Document Type: Article

References (53)

1. Laprise C, Lemire M, Sammak A, Verner A, Hudson TJ. Asthma genome scan in a French-Canadian founder population [abstract]. Am J Respir Crit Care Med 2003;169:A628.
2. Choudhry S, Mei R, Tsai HJ, Matsuzaki H, Tang H, Loi H, Matallana H, Dong S, Ung N, Narzarrio S, et al. Genome-wide association study of severe asthma among Puerto Ricans [abstract]. Proc Am Thorac Soc 2005;2:A31.
3. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999;56:104-132.
4. Waltz DA, Fujita RM, Yang X, Natkin L, Zhuo S, Gerard CJ, Rosenberg S, Chapman HA. Nonproteolytic role for the urokinase receptor in cellular migration in vivo. Am J Respir Cell Mol Biol 2000;22:316-322.
5. Brooks AM, Bates ME, Vrtis RF, Jarjour NN, Bertics PJ, Sedgwick JB. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma. Am J Respir Cell Mol Biol 2006;35:503-511.
6. Gyetko MR, Sud S, Sonstein J, Polak T, Sud A, Curtis JL. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J Immunol 2001;167:5539-5542.
7. Chu EK, Foley JD, Cheng J, Drazen JM, Tschumperlin DJ. Mechanical regulation of the urokinase system as a potential mediator of remodeling in a human cell culture of asthma [abstract]. Proc Am Thorac Soc 2005;2:A517.
8. Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 2004;5:21-30.
9. Buckova D, Izakovicova Holla L, Vacha J. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy 2002;57:446-448.
10. Finckh U, van Hadeln K, Muller-Thomsen T, Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Gal A. Association of lateonset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics 2003;4:213-217.
11. Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, et al. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum Mol Genet 2006;15:2446-2456.
12. Przybylowska K, Smolarczyk K, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Blasiak J. Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. Cancer Lett 2002;181:23-30.
13. Huang CM, Chen CL, Tsai JJ, Tsai CH, Tsai FJ. Association between urokinase gene 3′-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 2004;22:219-222.
14. Chou HT, Chen YT, Wu JY, Tsai FJ. Association between urokinase-plasminogen activator gene T4065C polymorphism and risk of mitral valve prolapse. Int J Cardiol 2004;96:165-170.
15. Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC. Urokinase gene 3′-UTR T/C polymorphism is associated with urolithiasis. Urology 2002;59: 458-461.
16. Ozturk A, Minster RL, DeKosky ST, Kamboh MI. Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits.Am J Med Genet B Neuropsychiatr Genet 2007;144:79-82.
17. Begin P, Provost V, Page N, Hudson TJ, Laviolette M, Laprise C. Association between the PLAU gene and asthma in a French Canadian population [abstract]. Proc Am Thorac Soc 2005;2:A620.
18. Laitinen T, Daly MJ, Rioux JD, Kauppi P, Laprise C, Petays T, Green T, Cargill M, Haahtela T, Lander ES, et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 2001;28:87-91.
19. Heyer E, Tremblay M. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am J Hum Genet 1995;56:970-978.
20. Labuda M, Labuda D, Korab-Laskowska M, Cole DE, Zietkiewicz E, Weissenbach J, Popowska E, Pronicka E, Root AW, Glorieux FH. Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet 1996;59:633-643.
21. Scriver CR. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2001;2:69-101.
22. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
23. Poon AH, Laprise C, Lemire M, Montpetit A, Sinnett D, Schurr E, Hudson TJ. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med 2004; 170:967-973.
24. European Academy of Allergology and Clinical Immunology. Skin tests used in type I allergy testing position paper: Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989;44(suppl. 10):1-59.
25. Chan-Yeung M, Manfreda J, Dimich-Ward H, Ferguson A, Watson W, Becker A. A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch Pediatr Adolesc Med 2000;154:657-663.
26. Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M, Dybuncio A, Becker A. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005;116:49-55.
27. Becker A, Watson W, Ferguson A, Dimich-Ward H, Chan-Yeung M. The Canadian Asthma Primary Prevention Study: outcomes at 2 years of age. J Allergy Clin Immunol 2004;113:650-656.
28. Godfrey S. Bronchial hyper-responsiveness in children. Paediatr Respir Rev 2000;1:148-155.
29. Godfrey S, Springer C, Bar-Yishay E, Avital A. Cut-off points defining normal and asthmatic bronchial reactivity to exercise and inhalation challenges in children and young adults. Eur Respir J 1999;14:659-668.
30. Riccio A, Grimaldi G, Verde P, Sebastio G, Boast S, Blasi F. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res 1985;13:2759-2771.
31. Kwok PY. SNP genotyping with fluorescence polarization detection. Hum Mutat 2002;19:315-323.
32. Lake SL, Blacker D, Laird NM. Family-based tests of association in the presence of linkage. Am J Hum Genet 2000;67:1515-1525.
33. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004;26:61-69.
34. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000;19:S36-S42.
35. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120: 849-852.
36. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
37. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
38. Laird N, Horvath S, Xu X. Implementing a unified approach to family based tests of association. Genetic Epidemiol 2000;19(suppl. 1):S36-S42.
39. Dumler I, Weis A, Mayboroda OA, Maasch C, Jerke U, Haller H, Gulba DC. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 1998;273:315-321.
40. Bernstein AM, Greenberg RS, Taliana L, Masur SK. Urokinase anchors uPAR to the actin cytoskeleton. Invest Ophthalmol Vis Sci 2004;45: 2967-2977.
41. Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999;147:89-104.
42. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 2003; 170:5644-5651.
43. Gyetko MR, Libre EA, Fuller JA, Chen GH, Toews G. Urokinase is required for T lymphocyte proliferation and activation in vitro. J Lab Clin Med 1999;133:274-288.
44. Gyetko MR, Sud S, Chen GH, Fuller JA, Chensue SW, Toews GB. Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection. J Immunol 2002;168:801-809.
45. Gyetko MR, Sud S, Chensue SW. Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge. Infect Immun 2004;72:461-467.
46. Hansen AP, Petros AM, Meadows RP, Nettesheim DG, Mazar AP, Olejniczak ET, Xu RX, Pederson TM, Henkin J, Fesik SW. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 1994;33:4847-4864.
47. Bdeir K, Kuo A, Sachais BS, Rux AH, Bdeir Y, Mazar A, Higazi AA, Cines DB. The kringle stabilizes urokinase binding to the urokinase receptor. Blood 2003;102:3600-3608.
48. Yoshimoto M, Ushiyama Y, Sakai M, Tamaki S, Hara H, Takahashi K, Sawasaki Y, Hanada K. Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. Biochim Biophys Acta 1996;1293:83-89.
49. Nanbu R, Menoud PA, Nagamine Y. Multiple instability-regulating sites in the 3′ untranslated region of the urokinase-type plasminogen activator mRNA. Mol Cell Biol 1994;14:4920-4928.
50. Tran H, Maurer F, Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 2003;23:7177-7188.
51. Malerba G, Pignatti PF. A review of asthma genetics: gene expression studies and recent candidates. J Appl Genet 2005;46:93-104.
52. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-362.
53. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006;7:95-100.